Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBKR vs GSK✓SelectedUSD · GSKIBKR vs GSK performance historyLatest closeAs of-5.90%11/20
Stock and ETF performance explorer

IBKR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+284.2%
GSK return
+40.7%
Excess return
+243.6%
Maximum drawdown
-38.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.9%-0.1%-5.8%-5.9%
7D-13.0%-5.3%-7.6%-12.5%
30D-16.6%-3.7%-12.9%-16.3%
3M-20.7%-7.3%-13.4%-20.1%
6M-14.9%-4.2%-10.6%-14.8%
YTD+11.0%+0.9%+10.2%+10.1%
1Y+16.1%+7.3%+8.9%+14.1%
3Y+265.9%+52.7%+213.1%+224.2%
All+284.2%+40.7%+243.6%+212.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling